WO2010107734A3 - Methods for detecting endometriosis - Google Patents

Methods for detecting endometriosis Download PDF

Info

Publication number
WO2010107734A3
WO2010107734A3 PCT/US2010/027395 US2010027395W WO2010107734A3 WO 2010107734 A3 WO2010107734 A3 WO 2010107734A3 US 2010027395 W US2010027395 W US 2010027395W WO 2010107734 A3 WO2010107734 A3 WO 2010107734A3
Authority
WO
WIPO (PCT)
Prior art keywords
sample
level
mammal
methods
detecting endometriosis
Prior art date
Application number
PCT/US2010/027395
Other languages
French (fr)
Other versions
WO2010107734A2 (en
Inventor
Ozgul Muneyyirci-Delale
Original Assignee
Ozgul Muneyyirci-Delale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ozgul Muneyyirci-Delale filed Critical Ozgul Muneyyirci-Delale
Priority to US13/256,770 priority Critical patent/US20120059228A1/en
Publication of WO2010107734A2 publication Critical patent/WO2010107734A2/en
Publication of WO2010107734A3 publication Critical patent/WO2010107734A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The method of the present invention is directed towards detecting endometriosis in a mammalian subject. This method comprises the following steps; taking a sample from the mammal, measuring the level of sphingomyelin (SM) or phosphatidylcholine (PC), or combinations thereof, in the sample, comparing the measured levels of SM or PC, or combinations thereof, to predetermined levels, and diagnosing the mammal based on the comparison. This method may also comprise the following steps: taking a sample from the mammal, measuring the level of F11 Receptor (F11R) in the sample, comparing the measured level of F11R to a predetermined level, and diagnosing the mammal based on the comparison.
PCT/US2010/027395 2009-03-16 2010-03-16 Methods for detecting endometriosis WO2010107734A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/256,770 US20120059228A1 (en) 2009-03-16 2010-03-16 Methods for detecting endometriosis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16048609P 2009-03-16 2009-03-16
US16047609P 2009-03-16 2009-03-16
US61/160,476 2009-03-16
US61/160,486 2009-03-16

Publications (2)

Publication Number Publication Date
WO2010107734A2 WO2010107734A2 (en) 2010-09-23
WO2010107734A3 true WO2010107734A3 (en) 2011-03-10

Family

ID=42740184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/027395 WO2010107734A2 (en) 2009-03-16 2010-03-16 Methods for detecting endometriosis

Country Status (1)

Country Link
WO (1) WO2010107734A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150185238A1 (en) 2012-05-31 2015-07-02 Helmholtz Zentrum Munchen Novel method for the diagnosis of endometriosis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020127555A1 (en) * 2000-02-25 2002-09-12 Soheyl Baban Endometriosis-related markers and uses thereof
US20030219835A1 (en) * 2002-02-13 2003-11-27 Metriogene Biosciences Inc. CD16b as a marker for the diagnosis of endometriosis
US20070264270A1 (en) * 2004-12-22 2007-11-15 Barnhart Kurt T Endometriosis markers
US20070287676A1 (en) * 2006-05-16 2007-12-13 Sun-Wei Guo Diagnosis and treatment of endometriosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020127555A1 (en) * 2000-02-25 2002-09-12 Soheyl Baban Endometriosis-related markers and uses thereof
US20030219835A1 (en) * 2002-02-13 2003-11-27 Metriogene Biosciences Inc. CD16b as a marker for the diagnosis of endometriosis
US20070264270A1 (en) * 2004-12-22 2007-11-15 Barnhart Kurt T Endometriosis markers
US20070287676A1 (en) * 2006-05-16 2007-12-13 Sun-Wei Guo Diagnosis and treatment of endometriosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DAMIROV MM. ET AL.: "Change in phospholipid content in platelets, immunocompe tent cells and myometrial tissue in patients with internal endometriosis", AKUSH GINEKOL (MOSK), no. 1, 1994, pages 44 - 47 *

Also Published As

Publication number Publication date
WO2010107734A2 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
BRPI0915619A2 (en) methods for determining a probability that a subject has contributed genetic material to the genetic material test sample, to characterize genetic material test sample, and to determine whether a person of interest has contributed genetic material to a genetic material test sample , genetic material test sample analysis kit, and system to determine if a subject has contributed genetic material to a sample
WO2013093635A3 (en) Plasma micrornas for the detection of early colorectal cancer
WO2012074972A3 (en) Non-destructive testing methods for fuel cell interconnect manufacturing
EP2804001A3 (en) Methods for diagnosing prostate carcinomas
WO2012042211A3 (en) Glucose electrochemical measurement method with error detection
MX339815B (en) Underfill management system for a biosensor.
WO2009104016A3 (en) Methods of calibrating a sensor in a patient monitoring system
BR112012024945A2 (en) electrochemical analyte measurement system and method
PL2419706T3 (en) Method and sample for testing a measuring instrument for gravimetric moisture determination
WO2010011578A3 (en) Computer-implemented methods for inspecting and/or classifying a wafer
WO2009063840A1 (en) Method and kit for measurement of endotoxin level
WO2012031181A3 (en) Method and device for sensing corrosion under insulation (cui)
WO2007090126A3 (en) Compositions and methods for detecting and quantifying toxic substances in disease states
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
WO2012058579A3 (en) In-situ downhole x-ray core analysis system
WO2014077925A3 (en) Apparatus and method for measuring total air temperature within an airflow
BR112013021666A2 (en) capacitance detection in electrochemical assay with improved sampling time compensation
WO2009090562A3 (en) Light scattering measurements using simultaneous detection
CA2726071A1 (en) Blood glucose monitoring device
EP3182126A3 (en) Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
WO2012032345A3 (en) Biomarker signatures and uses thereof
JP2011252930A5 (en)
EP2569635A4 (en) Methods for diagnosing and treating encephalitis or epilepsy
WO2007082757A3 (en) Test systems for the analysis of polypeptides and cells adhering to silicones

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10753951

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13256770

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 10753951

Country of ref document: EP

Kind code of ref document: A2